The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus (Adv. Sci. 27/2023)
In article number 2207108, Nan Shen, Hongyan Wang, Bin Wei, and co-workers report elevated plasma levels of 7α,25-dihydroxycholesterol, but its receptor EBI2 is reduced in monocyte/macrophages from patients and mice with systemic lupus erythematosus (SLE). EBI2-deficient macrophages produce higher levels of IFN-I, chemokines and cytokines, which further recruits and activates T and B lymphocytes to exacerbate the development of SLE.
© 版权声明
本站部分文章及资源内容可能来源于网络或公开渠道，仅供学习交流与参考使用，不代表本站立场，也不代表本站认可其观点或对其真实性负责；本站禁止发布或转载任何违法违规信息，如发现侵权、违规内容或资源链接失效，请及时联系站长微信 li19198015786，我们将在核实后尽快删除、处理或更新。
THE END
暂无评论内容